Detalles de la búsqueda
1.
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial.
Am Heart J
; 178: 37-44, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27502850
2.
Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model.
Eur Heart J
; 33(1): 120-8, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21733913
3.
A fibronectin-fibrinogen-tropoelastin coating reduces smooth muscle cell growth but improves endothelial cell function.
J Cell Mol Med
; 16(9): 2117-26, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22225866
4.
Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.
Atherosclerosis
; 321: 39-44, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33639478
5.
Efficiency of statin treatment on EPC recruitment depends on baseline EPC titer and does not improve angiographic outcome in coronary artery disease patients treated with the Genous stent.
Cell Transplant
; 23(12): 1525-35, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-23561893
6.
Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients.
Atherosclerosis
; 219(1): 245-52, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21763653
Resultados
1 -
6
de 6
1
Próxima >
>>